Prophylactic ICD Cost Considerations: Will They Upstage MCAC Data Review?
This article was originally published in The Gray Sheet
Executive Summary
CMS' referral to the Medicare Coverage Advisory Committee of a national coverage determination for an expanded ICD indication raises the bar for the type of clinical evidence needed to secure reimbursement